Ambulatory pathway for oncology patients presenting with low risk Febrile Neutropenia

Ambulatory pathway for oncology patients presenting with low risk Febrile Neutropenia has been published.

This document is offered as a template for use by trusts/hospitals wishing to develop a pathway for the ambulatory management of patients with low risk febrile neutropenia.

Click here for the document.

Latest News

By Joseph Williams on 13th February 2026

Canadian Association of Pharmacy in Oncology (CAPhO) Conference – April 23 to 26, 2026

The CAPhO Conference 2026, presented by the Canadian Association of Pharmacy in Oncology (CAPhO), will take place from April 23 to 26, 2026 at the TCU Place, in Saskatoon, Saskatchewan.…

Read article
By ISOPP and FIP on 13th February 2026

ISOPP CPD Bites with FIP

The International Pharmaceutical Federation (FIP), in collaboration with ISOPP, has developed a series of short, practice-oriented videos designed to provide pharmacists with simple, up-to-date information that will empower them with the…

Read article
By BOPA on 12th February 2026

UK Board publishes collaborative proposals for the future of pharmacy professional leadership as part of the Royal College of Pharmacy

UK Board publishes collaborative proposals for the future of pharmacy professional leadership as part of the Royal College of Pharmacy The UK Pharmacy Professional Leadership Advisory Board has today published…

Read article
By Caoimhe Keenan on 6th February 2026

Improving Data Collection Quality and Completeness for Systemic Anti-Cancer Therapy (SACT) in Prostate Cancer – Upcoming Webinar

Join the National Prostate Cancer Audit (NPCA) and National Cancer Audit Collaborating Centre (NATCAN) for our next quality improvement webinar on Thursday 19th March 2026 at 09:00 am. Bringing together data managers, clinicians, allied healthcare professionals, and other relevant stakeholders,…

Read article